Home › Funds › Farrow Financial, Inc. › DGX

Farrow Financial, Inc. position in DGX

QUEST DIAGNOSTICS INC · Health Care

Farrow Financial, Inc. reported holding 13,396 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$3.1M, representing 1.66% of its reported portfolio and ranking #22 among its reported holdings. Farrow Financial, Inc. has disclosed DGX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)13.40K sh
Reported value held$3.12M
Portfolio Weight1.66%
First reportedQ4 2023
Last changeHold
Updated2026-10-30

Last updated: 2026-10-30 · Source: SEC EDGAR Form 13F-HR

How Farrow Financial, Inc.'s DGX position evolved

Farrow Financial, Inc. first disclosed a stake in DGX in Q4 2023 at 13,543 shares (US$1.9M). The position peaked in Q3 2026 at 13,396 shares, worth US$3.1M. Across 12 filings, Farrow Financial, Inc. increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 13,396 shares valued at US$3.1M.

Quarter by quarter

QuarterSharesValueChange
Q4 2023 13.54K $1.87M New
Q1 2024 15.13K $2.01M Add
Q2 2024 15.28K $2.09M Add
Q3 2024 14.79K $2.30M Reduce
Q4 2024 14.72K $2.22M Hold
Q1 2025 14.19K $2.40M Reduce
Q2 2025 13.99K $2.51M Reduce
Q3 2025 13.96K $2.66M Hold
Q4 2025 13.67K $2.37M Reduce
Q1 2026 13.31K $2.61M Reduce
Q2 2026 13.42K $2.84M Add
Q3 2026 13.40K $3.12M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 31 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has Farrow Financial, Inc. held DGX?

Farrow Financial, Inc. has disclosed DGX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Farrow Financial, Inc.'s current position in DGX?

As of Q3 2026, Farrow Financial, Inc. holds 13.40K shares of DGX (QUEST DIAGNOSTICS INC), valued at $3.12M, representing 1.66% of its reported portfolio and ranking #22.

Has Farrow Financial, Inc. been buying or selling DGX?

In the latest 13F filing (Q3 2026), Farrow Financial, Inc. held unchanged its position in DGX. The position peaked in Q3 2026 at 13.40K shares.

Which other funds hold DGX?

Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.